Drug Master Files for: ATAZANAVIR SULFATE
✉ Email this page to a colleague
ATAZANAVIR SULFATE Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 19856 | A | II | 12/6/2006 | EMCURE PHARMACEUTICALS LTD | ATAZANAVIR SULFATE |
| 20419 | A | II | 3/27/2007 | MYLAN LABORATORIES LTD | ATAZANAVIR SULFATE |
| 20559 | A | II | 5/18/2007 | OLON SPA | ATAZANAVIR SULFATE |
| 21967 | A | II | 3/26/2009 | CIPLA LTD | ATAZANAVIR SULPHATE |
| 23611 | A | II | 4/12/2010 | LUPIN LTD | ATAZANAVIR SULFATE |
| 24970 | I | II | 5/24/2011 | SUN PHARMACEUTICAL INDUSTRIES LTD | ATAZANAVIR SULFATE |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
